1Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002[J].CA Cancer J Clin.2005,55(2):74-108.
2Medical Research Council of esophageal Cancer Working Party.Surgical resection with or without preoperative chemotherapy in esophageal cancer:A randomized controlled trial[J].Lancet,2002,359(9319):1727-1733.
3Urshel JD,Vasan H,Blewett CJ.A Meta-analysis of randomized conrolled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for respectable esophageal cancer[J].Am J Surg,2002,183(2):274-278.
4Malthaner R,Fenlon D.Preoperative chemotherapy for respect-able thoracic esophageal cancer[J].The Cochrane Database of Systemic Reviews,2003,Issue 4.Art No.CD001556.
5Kaklamanos IG,Walker GR,Ferry K,et al.Neoadjuvant treatment for respectable cancer of the esophagus and the gastro-esophageal junction:a meta-analysis of randomized clinical trials[J].Ann Surg Oncol 2003,10(7):754-758.
6Forshaw MJ,Gossage JA,Mason RC.Neoadjuvant chemotherapy for esophageal cancer:the need for accurate response prediction and evaluation[J].The Surgeon,2005,3(6):373-382.
7Leonard GD,Reilly EM.Post-operative chemotherapy improves disease-free survival,but not overall survival in people with esophageal squamous cell carcinoma[J].Cancer Treat Rev,2004,30(5):473-477.
8Armanios M,Xu R,Forastiere AA,et al.Adjuvant chemotherapy for resected adenocarcinoma of the esophagus,gastro-esophageal junction and cardia:phase Ⅱ trial(E8296) of the Eastern Cooperative Oncology Group[J].J Clin Oncol,2004,22(22):4495-4499.
5Hertel L W,Boder GB, Kroin JS,et al. Evaluation of the antitumor activity of gemcitabine (2, 2-deoxycytidine). Cancer Res, 1990,50 (14): 4417～4422.
6Moorsel CJAV, Veerman G, Bergman AM, et al. Combination chemotherapy studies with gemcitabine. Semin Oncol, 1997, 24(2): 17～23 (Suppl 17).
7[1]Fellous A, Meininger V, Binet S, et al. Action of nevelbin (NVB) on microtubules- role oftan and MAP2 proteins: Pierre fabre oncology. In: Mavelbine: Update and new trends. 1st ed. France: John Libbey Eurotest Ltd, 1991, 9
8[2]Conroy T, Etienne PL, Adenis A, et al. vinorelbine (Navelbine): A promising drug in metastatic eoidermoid esophageal carcinoma. Proc Am Soc Clin, 1993, 12:A553
9[3]Chevalier TL, Briggand D, Douillard JY, et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorellbine alone in advanced non-small-cell lung cancer:Results of a European multicencter trial including 612 patients.Clin Oncol, 1994, 12 (2) :360
10[7]Faulds D. Current option in the treatment of non small cell lung cancer. Drugs, 1992, 44 (Suppl 4) :46
